stockrowThe Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
Follow CC
Alert me
The Chemours Company (CC) Revenue
The Chemours Company's revenue for fiscal 2025 was $5.8B, unchanged from fiscal 2024. Over the twelve months to 30 September 2026 it was $5.8B. Over the past ten years it has ranged from $5.0B (fiscal 2020) to $6.8B (fiscal 2022); the current reading is higher than 55% of that period. The Chemours Company ranks 15th of 58 Specialty Chemicals companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $5.8B | 0.45% |
| FY2024 | $5.8B | (4.87%) |
| FY2023 | $6.1B | (11.02%) |
| FY2022 | $6.8B | 7.66% |
| FY2021 | $6.3B | 27.69% |
| FY2020 | $5.0B | (10.08%) |
| FY2019 | $5.5B | (16.75%) |
| FY2018 | $6.6B | 7.36% |
| FY2017 | $6.2B | 14.50% |
| FY2016 | $5.4B | (5.54%) |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $1.5B | (3.21%) |
| Jun 2026 | $1.6B | 15.21% |
| Mar 2026 | $1.4B | 3.83% |
| Dec 2025 | $1.3B | (11.04%) |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| CC The Chemours Company | $5.8B |
| FUL H. B. Fuller Company compare | $3.6B |
| SCL Stepan Company compare | $2.5B |
| MTX Minerals Technologies Inc. compare | $2.2B |
| KWR Quaker Houghton compare | $2.0B |
| IOSP Innospec Inc. compare | $1.9B |
| NGVT Ingevity Corporation compare | $1.2B |
| WDFC WD-40 Company compare | $688.0M |
| STDN Standard Nuclear Inc compare | — |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CC
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement